rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Nexavar

Rediff.com  »  News  »   Nexavar

  News for Nexavar

  • Business

Bayer to appeal against patent order on Nexavar

Bayer AG has said it will approach the high court in Mumbai against a ruling by Intellectual Property Appellate Board that upheld the compulsory licence issued to India's Natco Pharma to make and......

India must act fast to frame new IPR policy

Even as India prepares to sit for the first high-level dialogue on intellectual property rights (IPR) law and patents with the US on Monday, work on rolling out a 'National IPR Policy' has been......

3 Indian pharma firms named in US Congress price probe

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months The US Congress seems to have gone on the offensive against 14 generic drug manufacturers, including three......

US maintains status quo on India's patent regime

In its much-awaited Annual Special 301 Report, the US Trade Representative on Wednesday maintained status quo on India, by keeping it on a “priority watch list” for an allegedly lax......

PM urged to reject US pressure tactics on trade, biz policies

A group of India and American no-profit organisations and other groups have urged the Prime Minister, Manmohan Singh, not to succumb to the pressure of the US administration and reject the......
  Web results for Nexavar
Patented medicine and affordability

India's ongoing efforts at safeguarding its intellectual property rights (IPRs) have been facing challenges from different directions. In the... ...

http://www.thehindubusinessline.com/companies/patented-medicine-and-affordability/article6715292.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication
Novartis-Cipla battle shakes up Indian Pharma industry

The Indian pharmaceutical industry has been rocked by yet another high-profile patent battle between a local drug maker and a global giant. Swiss... ...

http://businesstoday.intoday.in/story/novartis-sues-cipla-indian-pharmaceutical-industry-onbrez/1/213643.html
Patented price gouging and the enduring enigma of drug costs

Given their excessive profits year after year, the prevalent perception is that big pharma is being overcompensated. Photo: AFP In a momentous... ...

http://www.livemint.com/Opinion/HchIwyVexY5dSaY7FjCNHO/Patented-price-gouging-and-the-enduring-enigma-of-drug-costs.html
SC Upholds Natco's Compulsory License

Published on Tue, Dec 16,2014|17:06, Updated at Tue, Dec 16 at 17:06Source : Moneycontrol.com In an order dated 12 December 2014,... ...

http://www.moneycontrol.com/news/the-firm/sc-upholds-natco%C3%A2%C2%80%C2%99s-compulsory-license_1253853.html
SC rejects Bayer's appeal against compulsory licence for Nexavar

Indian pharma company, NATCO, can continue manufacturing generic version of liver and kidney cancer drug The Supreme Court on Friday rejected Bayer... ...

http://www.downtoearth.org.in/content/sc-rejects-bayers-appeal-against-compulsory-licence-nexavar

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z